The use of drotrecogin alfa recombinant activated protein C for severe sepsis in the critically burned patient: a new treatment approach

Burns. 2006 Sep;32(6):783-7. doi: 10.1016/j.burns.2006.02.021. Epub 2006 Aug 1.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Infective Agents / therapeutic use*
  • Blast Injuries / microbiology*
  • Burns / microbiology*
  • Critical Illness
  • Humans
  • Male
  • Middle Aged
  • Protein C / therapeutic use*
  • Recombinant Proteins / therapeutic use
  • Sepsis / drug therapy*

Substances

  • Anti-Infective Agents
  • Protein C
  • Recombinant Proteins
  • drotrecogin alfa activated